The Shionogi Qualicaps Group, entirely held by Shionogi directly or indirectly, manufactures and markets hard capsules in the pharmaceutical and nutritional markets.
It has three entities for production and sales - Japan, the US and Spain and claims to be the industry leader in Japan, taking more than 60 per cent share of the pharmaceutical hard capsules market.
"Steady market growth is expected for hard capsules in the health and nutrition sector. At the same time, as the pharmaceutical industry becomes increasingly global, it is critical for the hard capsule business to strengthen its manufacturing and marketing capabilities accordingly," said Tamotsu Adachi, Carlyle managing director.
Carlyle has expertise through a number of investments worldwide. By leveraging our know-how and experience, we can support the global management of the Shionogi Qualicaps Group and achieve further growth, he adds.
Under terms of the deal, due for completion by October 2005, Shionogi Qualicaps Co., Ltd., Shionogi Qualicaps, Inc., Shionogi Qualicaps, and Shionogi Europe will pass to the private equity firm.
"Current management will remain in place and all employees will be retained," said Carlyle, without disclosing financial terms.